1World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. World Health Organization, 1992.
2Baxter, D, Appleby, L. Case register of suicide risk in mental disorders. Br J Psychiatry 1999; 175: 322–6.
3Bender, DS, Dolan, RT, Skodol, AE. Treatment utilization by patients with personality disorders. Am J Psychiatry 2001; 158: 295–302.
4Coid, J, Yang, M, Bebbington, P, Moran, P, Brugha, T, Jenkins, R, et al. Borderline personality disorder: Health service use and social functioning among a national household population. Psychol Med 2009; 39: 1721–31.
5Dale, O, Sethi, F, Stanton, C, Evans, S, Barnicot, K, Sedgwick, R, et al. Personality disorder services in England: findings from a national survey. Br J Psychiatry Bull 2017; 41: 247–53.
6National Institute for Health and Care Excellence. Borderline Personality Disorder: Recognition and Management. NICE guideline CG78. NICE, 2009. Available from https://www.nice.org.uk/guidance/cg78.
8Paris, J. Is hospitalization useful for suicidal patients with borderline personality disorder? J Pers Disord 2004; 18: 240–7.
10American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (5th edn). American Psychiatric Association, 2013.
11StataCorp. Stata Statistical Software: Release 13. StataCorp LP, 2013.
12Chiesa, M, Fonagy, P, Holmes, J, Drahorad, C, Harrison-Hall, A. Health service use costs by personality disorder following specialist and non-specialist treatment: a comparative study. J Pers Disord 2002; 16: 160–73.
13Flynn, S, Raphael, J, Graney, J, Nyathi, T, Williams, A, Kapur, N, et al. The personality disorder patient pathway: Service user and clinical perspectives. Personal Ment Health 2019; 13: 134–43.
14Soloff, PH, Chiappetta, L. Prospective predictors of suicidal behaviour in borderline personality disorder at 6-year follow-up. Am J Psychiatry 2012; 169: 484–90.
15Ogrodniczuk, JS, Piper, WE. Day treatment for personality disorders: a review of research findings. Harv Rev Psychiatry 2001; 9: 105–17.
16Karterud, S, Pedersen, G, Bjordal, E, Brabrand, J, Friis, S, Haaseth, O, et al. Day treatment of patients with personality disorders: experiences from a Norwegian treatment research network. J Pers Disord 2003; 17: 243–62.
17David, DO, Freeman, A. Overview of cognitive-behavioral therapy of personality disorders. In Cognitive Therapy of Personality Disorders (ed Beck, AT, Davis, DD, A Freeman, ): 3–18. The Guilford Press, 2015.
18Davidson, K, Norrie, J, Tyrer, P, Gumley, A, Tata, P, Murray, H, et al. The effectiveness of cognitive behaviour therapy for borderline personality disorder: results from the borderline personality disorder study of cognitive therapy (boscot) trial. J Pers Disord 2006; 20: 450–65.
19Soeteman, DI, Verheul, R, Meerman, AM, Ziegler, U, Rossum, BV, Delimon, J, et al. Cost-effectiveness of psychotherapy for cluster C personality disorders: a decision-analytic model in the Netherlands. J Clin Psychiatry 2010; 72: 51–9.
20Livesley, WJ. Moving beyond specialized therapies for borderline personality disorder: the importance of integrated domainfocused treatment. Psychodyn Psychiatry 2012; 40: 47–74.
21Bateman, AW, Gunderson, J, Mulder, R. Treatment of personality disorder. Lancet 2015; 385: 735–43.
22Cowdry, RW, Gardner, DL. Pharmacotherapy of borderline personality disorder. Arch Gen Psychiatry 1988; 1988: 111–9.
23Ripoll, LH, Triebwasser, J, Siever, LJ. Evidence-based pharmacotherapy for personality disorders. Int J Neuropsychopharmacol 2011; 14: 1257–88.
24Fok, ML, Hayes, RD, Chang, CK, Stewart, R, Callard, FJ, Moran, P. Life expectancy at birth and all-cause mortality among people with personality disorder. J Psychosom Res 2012; 73: 104–7.
25Stone, MH. Long-term outcome in personality disorders. Br J Psychiatry 1993; 162: 299–313.